Moderna

Read More
Less

Phase I trial begins for Moderna's mRNA HIV vaccine

Since AIDS was first identified, over 36 million deaths have been attributed to it worldwide.

A health worker is seen preparing to administer the a third COVID-19 booster shot (illustrative).

Omicron: UKHSA finds boosters provide 95% protection against death

For Moderna, effectiveness against hospitalization was 90-95% up to 9 weeks after the booster.

By REUTERS
27/01/2022

Pfizer CEO: COVID-19 will continue to circulate for many years

Bourla along with Moderna CEO Stéphane Bancel said last week that they are preparing a booster that will treat the newly-introduced Omicron variant.

17/01/2022

COVID-19: Pfizer and Moderna prepare vaccine against Omicron

The CEOs of Pfizer and Moderna say they are preparing a booster targeting Omicron. Pfizer CEO Albert Bourla is still unsure if there is a need for the fourth booster.

COVID-19 vaccine lengthens menstrual cycle, no indication of danger - study

Receiving the COVID-19 vaccine lengthens the menstrual cycle - not bleeding - by less than a day, though it seems to be temporary, is considered a normal variation and is not dangerous.

2021 was the year of the coronavirus vaccine

“I think we are in a revolution that no one believed would happen.”

Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syring

COVID-19: Moderna could be ready to develop Omicron booster in weeks - CEO

Moderna hopes to start clinical trials early next year on a vaccine to protect against the fast-spreading Omicron variant.

By REUTERS
21/12/2021

Moderna's mRNA-based flu vaccine shows promise in early-stage study

This data, though limited, puts Moderna ahead of other drugmakers, including rival Pfizer Inc, that are also testing their flu vaccine based on messenger RNA.

By REUTERS
10/12/2021
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syring

Moderna CEO: Vaccine likely less effective against Omicron COVID variant

"There is no world, I think, where (the effectiveness) is the same level we had with Delta," said the CEO of Moderna.

By REUTERS
30/11/2021
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy